Cortisol/NN
resistance/NN
in/IN
acquired/VBN
immunodeficiency/NN
syndrome/NN
./.

This/DT
study/NN
concerns/VBZ
9/CD
iv/NN
drug/NN
abusers/NNS
with/IN
acquired/VBN
immunodeficiency/NN
syndrome/NN
(/(
AIDS/NN
)/)
who/WP
developed/VBD
hypercortisolism/NN
without/IN
the/DT
clinical/JJ
signs/NNS
or/CC
metabolic/JJ
consequences/NNS
of/IN
hypercortisolism/NN
./.
=====
All/DT
patients/NNS
were/VBD
characterized/VBN
by/IN
an/DT
Addisonian/JJ
picture/NN
(/(
weakness/NN
,/,
weight/NN
loss/NN
,/,
hypotension/NN
,/,
hyponatremia/NN
,/,
and/CC
intense/JJ
mucocutaneous/JJ
melanosis/NN
)/)
./.
=====
An/DT
acquired/JJ
form/NN
of/IN
peripheral/JJ
resistance/NN
to/TO
glucocorticoids/NNS
was/VBD
suspected/VBN
./.
=====
We/PRP
,/,
therefore/RB
,/,
examined/VBD
glucocorticoid/NN
receptor/NN
characteristics/NNS
on/IN
mononuclear/JJ
leukocytes/NNS
by/IN
measuring/VBG
[3H]dexamethasone/NN
binding/NN
and/CC
the/DT
effect/NN
of/IN
dexamethasone/NN
on/IN
[3H]thymidine/NN
incorporation/NN
,/,
which/WDT
is/VBZ
one/CD
of/IN
the/DT
effects/NNS
of/IN
glucocorticoid/NN
receptor/NN
activation/NN
./.
=====
Glucocorticoid/NN
receptor/NN
density/NN
was/VBD
increased/VBN
in/IN
AIDS/NN
patients/NNS
with/IN
an/DT
Addisonian/JJ
picture/NN
(/(
group/NN
1/CD
;/:
16.2/CD
+/-/CC
9.4/CD
fmol/million/NN
cells/NNS
)/)
compared/VBN
to/TO
values/NNS
in/IN
12/CD
AIDS/NN
patients/NNS
without/IN
an/DT
Addisonian/JJ
picture/NN
(/(
group/NN
2/CD
;/:
6.05/CD
+/-/CC
2.6/CD
fmol/million/NN
cells/NNS
;/:
P/NN
less/JJR
than/IN
0.01/CD
)/)
and/CC
sex-/NN
and/CC
age-matched/JJ
controls/NNS
(/(
3.15/CD
+/-/CC
2.3/CD
fmol/million/NN
cells/NNS
;/:
P/NN
less/JJR
than/IN
0.01/CD
)/)
./.
=====
The/DT
affinity/NN
of/IN
glucocorticoid/NN
receptors/NNS
(/(
Kd/NN
)/)
was/VBD
strikingly/RB
decreased/VBN
(/(
9.36/CD
+/-/CC
3.44/CD
nM/NN
in/IN
group/NN
1/CD
;/:
3.2/CD
+/-/CC
1.5/CD
nM/NN
in/IN
group/NN
2/CD
;/:
2.0/CD
+/-/CC
0.8/CD
nM/NN
in/IN
controls/NNS
;/:
P/NN
less/JJR
than/IN
0.01/CD
)/)
./.
=====
[3H]Thymidine/NN
incorporation/NN
was/VBD
decreased/VBN
dose-dependently/RB
by/IN
dexamethasone/NN
in/IN
controls/NNS
and/CC
patients/NNS
;/:
the/DT
effect/NN
was/VBD
significantly/RB
blunted/VBN
(/(
P/NN
less/JJR
than/IN
0.05/CD
)/)
in/IN
group/NN
1/CD
patients/NNS
,/,
which/WDT
suggests/VBZ
that/IN
activation/NN
of/IN
glucocorticoid/NN
receptor/NN
is/VBZ
impaired/JJ
as/IN
a/DT
result/NN
of/IN
the/DT
glucocorticoid/NN
receptor/NN
abnormality/NN
./.
=====
In/IN
conclusion/NN
,/,
AIDS/NN
patients/NNS
with/IN
hypercortisolism/NN
and/CC
clinical/JJ
features/NNS
of/IN
peripheral/JJ
resistance/NN
to/TO
glucocorticoids/NNS
are/VBP
characterized/VBN
by/IN
abnormal/JJ
glucocorticoid/NN
receptors/NNS
on/IN
lymphocytes/NNS
./.
=====
Resistance/NN
to/TO
glucocorticoids/NNS
implies/VBZ
a/DT
complex/JJ
change/NN
in/IN
immune-endocrine/JJ
function/NN
,/,
which/WDT
may/MD
be/VB
important/JJ
in/IN
the/DT
course/NN
of/IN
immunodeficiency/NN
syndrome/NN
./.